Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
RESEARCH TOOLSreports
Holding TRDA?
Track your performance easily
Entrada Therapeutics Inc (TRDA) Ownership Overview
40.54% Insiders
14.80% Mutual Funds
<0.01% Other Institutional Investors
8.08% ETFs
36.58% Public Companies and Individual Investors
The ownership structure of Entrada Therapeutics Inc (TRDA) stock is a mix of institutional, retail, and individual investors. Approximately 22.88% of the company’s stock is owned by Institutional Investors, 40.54% is owned by Insiders, and 36.58% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 12, 2024 | Mpm Bioventures 2018, L.p. >10% Owner | xxxxxxxxxxxxx | $917111 |
| Dec 12, 2024 | Mpm Bioventures 2014, L.p. >10% Owner | xxxxxxxxxxxxx | $917111 |
| May 16, 2024 | Peter Kim Director | xxxxxxxxxxxxx | $364500 |
| May 10, 2024 | Peter Kim Director | xxxxxxxxxxxxx | $63283 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $206429 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $916149 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,865,819 | Institution | 13.00% | 60,774,079 | |
| 4,501,658 | Insider | 12.03% | 56,225,708 | |
| 4,381,062 | Insider | 11.71% | 54,719,464 | |
| 4,381,062 | Insider | 11.71% | 54,719,464 | |
| 1,942,377 | Institution | 5.19% | 24,260,289 | |
| 1,302,140 | Institution | 3.48% | 16,263,729 | |
| 1,158,543 | Institution | 3.10% | 14,470,202 | |
| 1,132,357 | Insider | 3.03% | 14,143,139 | |
| 970,062 | Institution | 2.59% | 12,116,074 | |
| 581,298 | Institution | 1.55% | 7,260,412 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,942,377 | Institution | 5.19% | 24,260,289 | |
| 970,062 | Institution | 2.59% | 12,116,074 | |
| 581,298 | Institution | 1.55% | 7,260,412 | |
| 569,869 | Institution | 1.52% | 7,117,664 | |
| 279,408 | Institution | 0.75% | 3,489,806 | |
| 276,252 | Institution | 0.74% | 3,450,387 | |
| 195,225 | Institution | 0.52% | 2,438,360 | |
| 122,416 | Institution | 0.33% | 1,528,976 | |
| 118,764 | Institution | 0.32% | 1,483,362 | |
| 67,494 | Institution | 0.18% | 843,000 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 791,624 | Institution | 2.12% | 15,745,401 | |
| 658,390 | Institution | 1.76% | 8,223,291 | |
| 320,132 | Institution | 0.86% | 6,367,425 | |
| 225,961 | Institution | 0.60% | 2,822,253 | |
| 138,135 | Institution | 0.37% | 1,725,306 | |
| 115,969 | Institution | 0.31% | 2,306,623 | |
| 111,945 | Institution | 0.30% | 1,496,705 | |
| 73,749 | Institution | 0.20% | 921,125 | |
| 57,427 | Institution | 0.15% | 717,263 | |
| 55,264 | Institution | 0.15% | 1,099,201 |
FAQ
Who Owns Entrada Therapeutics Inc (TRDA)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 40.54% is held by insiders, and 36.58% is held by retail investors.
What percentage of Entrada Therapeutics Inc (TRDA) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Entrada Therapeutics Inc (TRDA) stock is held by institutional investors.
What percentage of Entrada Therapeutics Inc (TRDA) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.58% of Entrada Therapeutics Inc (TRDA) stock is held by retail investors.
Who owns the most shares of Entrada Therapeutics Inc (TRDA)?
Felix Baker owns the most shares of Entrada Therapeutics Inc (TRDA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.